Age-dependent differences in diabetes and acute hyperglycemia between men and women with ST-elevation myocardial infarction: A cohort study

Diabetology and Metabolic Syndrome

Volumn 5, Issue 1, 2013, Pages

  Otten, Amber M ^a   Ottervanger, Jan Paul ^a   Timmer, Jorik R ^a   van't Hof, Arnoud W J ^a   Dambrink, Jan Henk E ^a   Gosselink, A T Marcel ^a   Hoorntje, Jan C A ^a   Suryapranata, Harry ^a,b   Maas, Angela H E M ^b  

^a ISALA HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute Hyperglycemia; Diabetes; Gender; STEMI

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ACUTE DISEASE; ADULT; AGE; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 84879832136     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-5-34     Document Type: Article

References (25)

1. Timmer JR, Hoekstra M, Nijsten MWN, Van Der Horst IC, Ottervanger JP, Slingerland RJ, Dambrink JHE, Bilo HJ, Zijlstra F, Van T, Hof AWJ: Prognostic value of admissio glycosylated hemoglobin and glucose in nondiabetic patients with st-segment elevation myocartial infarction treates with percutaneous coronary intervention. Circulation 2011, 124:704-711.
2. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24:683-689.
3. Thalib L, Zubaid M, Rashed W, Suwaidi JA, Almahmeed W, Alozairi E, Alanbaei M, Sulaiman K, Amin H, Al-Motarreb A: Impact of diabetic status on the hyperglycemia-induced adverse risk of short term outcomes in hospitalized patients with acute coronary syndromes in the Middle East: Findings from the Gulf registry of Acute Coronary Events (Gulf RACE). Clin Med Res 2011, 9:32-37.
4. Monteiro S, Monteiro P, Gonçalves F, Freitas M, Providěncia LA: Hyperglycaemia at admission in acute coronary syndrome patients: Prognostic value in diabetics and non-diabetics. Eur J Cardiovasc Prev Rehabil 2010, 17:155-159.
5. Berger JS, Elliott L, Gallup D, Roe M, Granger CB, Armstrong PW, Simes RJ, White HD, Van de Werf F, Topol EJ, Hochman JS, Newby LK, Harrington RA, Califf RM, Becker RC, Douglas PS: Sex differences in mortality following acute coronary syndromes. JAMA 2009, 302:874-882.
6. Hailer B, Naber C, Koslowski B, Van Leeuwen P, Schäfer H, Budde T, Jacksch R, Sabin G, Erbel R, Myocardial Infarction Network Essen: Gender-related differences in patients with ST-elevation myocardial infarction: Results from the registry study of the ST elevation myocardial infarction network Essen. Clin Cardiol 2011, 34:294-301.
7. Hu G, Jousilahti P, Qiao Q, Peltonen M, Katoh S, Tuomilehto J: The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease. J Am Coll Cardiol 2005, 45:1413-1418.
8. Natarajan S, Liao Y, Cao G, Lipsitz SR, McGee DL: Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease. Arch Intern Med 2003, 163:1735-1740.
9. Huxley R, Barzi F, Woodward M: Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006, 332:73-78.
10. The Decode Study Group: Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003, 26:61-69.
11. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2012, 35:S64-S71.
12. The TIMI study group: The Thrombolysis in Myocardial Infarction (TIMI) trial: Phase 1 findings. N Engl J Med 1985, 312:932-936.
13. Mozaffarian D, Marfisi R, Levantesi G, Silletta MG, Tavazzi L, Tognoni G, Valagussa F, Marchioli R: Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle factors. Lancet 2007, 370:667-675.
14. Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ: Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study. Eur Heart J 2007, 28:2937-2943.
15. Gress TW, Nieto J, Shahar E, Wofford MR, Brancati FL: Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. N Engl J Med 2000, 43:905-912.
16. Bairey Merz CN, Kelsey SF, Pepine CJ, Reichek N, Reis SE, Rogers WJ, Sharaf BL, Sopko G: The Women's Ischemia Syndrome Evaluation (WISE) study: Protocol design, methodology and feasibility report. J Am Coll Cardiol 1999, 33:1453-1461.
17. Reis SE, Holubkov R, Lee JS, Sharaf B, Reichek N, Rogers WJ, Walsh EG, Fuisz AR, Kerensky R, Detre KM, Sopko G, Pepine CJ: Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease: Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study. J Am Coll Cardiol 1999, 33:1469-1475.
18. Wessel TR, Arant CB, McGorray SP, Sharaf BL, Reis SE, Kerensky RA, von Mering GO, Smith KM, Pauly DF, Handberg EM, Mankad S, Olson MB, Johnson BD, Merz CN, Sopko G, Pepine CJ: Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: Results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE). Clin Cardiol 2007, 30:69-74.
19. Waller BF, Palumbo PJ, Lie JT, Roberts WC: Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years: Analysis of 229 diabetic patients with and without clinical evidence of coronary heart disease and comparison to 183 control subjects. Am J Med 1980, 69:498-506.
20. Wiviott SD, Braunwald E, Angiolillo AJ, Meisel S, Dalby AJ, Verheugt FW, Goodman SG, Corbalan R, Purdy DA, Murphy SA, McCabe CH, Antman EM, EM; TRITON-TIMI 38 Investigators: Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38. Circulation 2008, 118:1626-1636.
21. Ferreiro JL, Angiolillo AJ: Diabetes and antiplatelet therapy in acute coronary syndrome. Circulation 2011, 123:798-813
22. Anatharaman R, Heatley M, Weston CF: Hyperglycemia in acute coronary syndromes: risk-marker or therapeutic target? Heart 2009, 95:697-703
23. Capes SE, Hunt D, Malmberg K, Gerstein HC: Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000, 355:773-778
24. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendíc S, Rydén L, Malmberg K: Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002, 359:2140-2144.
25. Koeth O, Zahn R, Heer T, Bauer T, Juenger C, Klein B, Gitt AK, Senges J, Zeymer U: Gender differences in patients with acute ST-elevation myocardial infarction complicated by cardiogenic shock. Clin Res Cardiol 2009, 98:781-786.